Morgan Stanley raised the firm’s price target on DocuSign (DOCU) to $97 from $62 and keeps an Equal Weight rating on the shares. Docusign is executing to its strategic plan with “several encouraging trends” driving outperformance in Q3 and stronger than expected Q4 billings guidance, the analyst tells investors. Fundamentally, metrics and commentary showed stabilization or improvement, but significant share outperformance and a stock in the mid-$90’s in the afterhours “suggests a bullish path ahead is well reflected in shares,” the analyst argues.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on DOCU:
- DocuSign price target raised to $115 from $95 at Jefferies
- DocuSign price target raised to $113 from $87 at Citi
- DocuSign price target raised to $124 from $108 at JMP Securities
- Docusign Reports Strong Q3 Fiscal 2025 Growth
- Closing Bell Movers: Lululemon jumps 9% after beat and raise
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
